Hugh Tunstall-Pedoe
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Hugh Tunstall-Pedoe has a total of 37 co-authors. Here are the top co-authors by number of shared publications:
- Kari Kuulasmaa
National Institute for Health and Welfare, Helsinki, Finland (J.K., K.K., V.S.).
5 shared publications Mark Woodward
Cardiovascular Epidemiology Unit, Institute of Cardiovascular Research, University of Dundee, United Kingdom
5 shared publications- Hanna Tolonen
Finnish Institute for Health and Welfare (THL) , Helsinki
2 shared publications - Jill Janette Freda Belch
University of Dundee Medical School, Dundee, Scotland, UK
2 shared publications - Maria Hughes
Queens University Belfast
2 shared publications Markku Mähönen
2 shared publications
Latest Publications
- Open Access
- 22 September 2017
- Published by Wolters Kluwer Health in Journal of the American Heart Association
- Vol. 6 (9) , e005967
Twenty‐Year Predictors of Peripheral Arterial Disease Compared With Coronary Heart Disease in the Scottish Heart Health Extended Cohort (SHHEC)
Background Coronary heart disease and peripheral arterial disease (PAD) affect different vascular territories. Supplementing baseline findings with assays from stored serum, we compared their 20‐year predictors. Methods and Results We randomly recruited 15 737 disease‐free men and women aged 30 to 75 years across Scotland between 1984 and 1995 and followed them through 2009 for death and hospital diagnoses. Of these, 3098 developed coronary heart disease (19.7%), and 499 PAD (3.2%). Hazard ratios for 45 variables in the Cox model were adjusted for age and sex and for factors in the 2007 ASSIGN cardiovascular risk score. Forty‐four of them were entered into parsimonious predictive models, tested by c‐statistics and net reclassification improvements. Many hazard ratios diminished with adjustment and parsimonious modeling, leaving significant survivors. The hazard ratios were mostly higher in PAD. New parsimonious models increased the c‐statistic and net reclassification improvements over ASSIGN variables alone but varied in their components and ranking. Coronary heart disease and PAD shared 7 of the 9 factors from ASSIGN: age, sex, family history, socioeconomic status, diabetes mellitus, tobacco smoking, and systolic blood pressure (but neither total nor high‐density lipoprotein cholesterol); plus 4 new ones: NT‐pro‐BNP, cotinine, high‐sensitivity C‐reactive protein, and cystatin‐C. The highest ranked hazard ratios for continuous factors in coronary heart disease were those for age, total cholesterol, high‐sensitivity troponin, NT‐pro‐BNP, cotinine, apolipoprotein A, and waist circumference (plus 10 more); in PAD they were age, high‐sensitivity C‐reactive protein, systolic blood pressure, expired carbon monoxide, cotinine, socioeconomic status, and lipoprotein (a) (plus 5 more). Conclusions The mixture of shared with disparate determinants for arterial disease in the heart and the legs implies nonidentical pathogenesis: cholesterol dominant in the former, and inflammation (high‐sensitivity C‐reactive protein, diabetes mellitus, smoking) in the latter.
- 22 September 2017
- Published by Wolters Kluwer Health in Journal of the American Heart Association
- Vol. 6 (9) , e005967
Open AccessTwenty‐Year Predictors of Peripheral Arterial Disease Compared With Coronary Heart Disease in the Scottish Heart Health Extended Cohort (SHHEC)
Background Coronary heart disease and peripheral arterial disease (PAD) affect different vascular territories. Supplementing baseline findings with assays from stored serum, we compared their 20‐year predictors. Methods and Results We randomly recruited 15 737 disease‐free men and women aged 30 to 75 years across Scotland between 1984 and 1995 and followed them through 2009 for death and hospital diagnoses. Of these, 3098 developed coronary heart disease (19.7%), and 499 PAD (3.2%). Hazard ratios for 45 variables in the Cox model were adjusted for age and sex and for factors in the 2007 ASSIGN cardiovascular risk score. Forty‐four of them were entered into parsimonious predictive models, tested by c‐statistics and net reclassification improvements. Many hazard ratios diminished with adjustment and parsimonious modeling, leaving significant survivors. The hazard ratios were mostly higher in PAD. New parsimonious models increased the c‐statistic and net reclassification improvements over ASSIGN variables alone but varied in their components and ranking. Coronary heart disease and PAD shared 7 of the 9 factors from ASSIGN: age, sex, family history, socioeconomic status, diabetes mellitus, tobacco smoking, and systolic blood pressure (but neither total nor high‐density lipoprotein cholesterol); plus 4 new ones: NT‐pro‐BNP, cotinine, high‐sensitivity C‐reactive protein, and cystatin‐C. The highest ranked hazard ratios for continuous factors in coronary heart disease were those for age, total cholesterol, high‐sensitivity troponin, NT‐pro‐BNP, cotinine, apolipoprotein A, and waist circumference (plus 10 more); in PAD they were age, high‐sensitivity C‐reactive protein, systolic blood pressure, expired carbon monoxide, cotinine, socioeconomic status, and lipoprotein (a) (plus 5 more). Conclusions The mixture of shared with disparate determinants for arterial disease in the heart and the legs implies nonidentical pathogenesis: cholesterol dominant in the former, and inflammation (high‐sensitivity C‐reactive protein, diabetes mellitus, smoking) in the latter.
- Open Access
- 21 June 2015
- Published by Oxford University Press (OUP) in International Journal of Epidemiology
- Vol. 44 (5) , 1602-1612
Prime mover or fellow traveller: 25-hydroxy vitamin D’s seasonal variation, cardiovascular disease and death in the Scottish Heart Health Extended Cohort (SHHEC)
Background: Theoretical links between seasonal lack of sunlight, hypovitaminosis D and excess cardiovascular disease and death prompted our adding novel to conventional cohort analyses. Methods: We tested three postulates on 13 224 Scottish Heart Health Extended Cohort participants, assayed for 25-hydroxyvitamin D (25OHD) and followed for 22 years. (i) Endpoints enumerated by month of occurrence mirror annual seasonal oscillation in 25OHD. (ii) Endpoint seasonality is increased in people with below median 25OHD. (iii) Low 25OHD predicts endpoints independently of major risk factors. Results: Baseline median 25OHD level was 36.4 (other quartiles 26.7, 51.7) nmol/l. The March trough was half the August peak, both well after seasonal solstices. (i) There was no demonstrable monthly variation in First Cardiovascular Event ( n = 3307). Peaks and troughs for All Death and Cardiovascular Death ( n = 2987, 1350) were near the solstices, earlier than extremes of 25OHD. (ii) Endpoint variability showed no difference between those above and below median 25OHD. (iii) Cox model hazard ratios (HR), by decreasing 25OHD, increased modestly and nonspecifically for all endpoints examined, with no threshold, the gradients diminishing by ∼ 60% following multiple adjustment. For Cardiovascular Disease, HR, by 20 (∼SD) nmol/l decrease, = 1.224 (1.175, 1.275) adjusted for age and sex; additionally adjusted for family history, deprivation index, smoking, systolic blood pressure, total and HDL cholesterol, = 1.093 (1.048, 1.139); All Deaths = 1.238 (1.048, 1.139) and 1.098 (1.050, 1.149). 25OHD made no independent contribution to cardiovascular discrimination and reclassification. Conclusions: Our analyses challenge vitamin D’s alleged role as major prime mover in cardiovascular disease and mortality.
- 21 June 2015
- Published by Oxford University Press (OUP) in International Journal of Epidemiology
- Vol. 44 (5) , 1602-1612
Open AccessPrime mover or fellow traveller: 25-hydroxy vitamin D’s seasonal variation, cardiovascular disease and death in the Scottish Heart Health Extended Cohort (SHHEC)
Background: Theoretical links between seasonal lack of sunlight, hypovitaminosis D and excess cardiovascular disease and death prompted our adding novel to conventional cohort analyses. Methods: We tested three postulates on 13 224 Scottish Heart Health Extended Cohort participants, assayed for 25-hydroxyvitamin D (25OHD) and followed for 22 years. (i) Endpoints enumerated by month of occurrence mirror annual seasonal oscillation in 25OHD. (ii) Endpoint seasonality is increased in people with below median 25OHD. (iii) Low 25OHD predicts endpoints independently of major risk factors. Results: Baseline median 25OHD level was 36.4 (other quartiles 26.7, 51.7) nmol/l. The March trough was half the August peak, both well after seasonal solstices. (i) There was no demonstrable monthly variation in First Cardiovascular Event ( n = 3307). Peaks and troughs for All Death and Cardiovascular Death ( n = 2987, 1350) were near the solstices, earlier than extremes of 25OHD. (ii) Endpoint variability showed no difference between those above and below median 25OHD. (iii) Cox model hazard ratios (HR), by decreasing 25OHD, increased modestly and nonspecifically for all endpoints examined, with no threshold, the gradients diminishing by ∼ 60% following multiple adjustment. For Cardiovascular Disease, HR, by 20 (∼SD) nmol/l decrease, = 1.224 (1.175, 1.275) adjusted for age and sex; additionally adjusted for family history, deprivation index, smoking, systolic blood pressure, total and HDL cholesterol, = 1.093 (1.048, 1.139); All Deaths = 1.238 (1.048, 1.139) and 1.098 (1.050, 1.149). 25OHD made no independent contribution to cardiovascular discrimination and reclassification. Conclusions: Our analyses challenge vitamin D’s alleged role as major prime mover in cardiovascular disease and mortality.
- Open Access
- 8 October 2013
- Published by Oxford University Press (OUP) in European Heart Journal
- Vol. 35 (5) , 271-281
High population prevalence of cardiac troponin I measured by a high-sensitivity assay and cardiovascular risk estimation: the MORGAM Biomarker Project Scottish Cohort
Our aim was to test the prediction and clinical applicability of high-sensitivity assayed troponin I for incident cardiovascular events in a general middle-aged European population. High-sensitivity assayed troponin I was measured in the Scottish Heart Health Extended Cohort (n = 15 340) with 2171 cardiovascular events (including acute coronary heart disease and probable ischaemic strokes), 714 coronary deaths (25% of all deaths), 1980 myocardial infarctions, and 797 strokes of all kinds during an average of 20 years follow-up. Detection rate above the limit of detection (LoD) was 74.8% in the overall population and 82.6% in men and 67.0% in women. Troponin I assayed by the high-sensitivity method was associated with future cardiovascular risk after full adjustment such as that individuals in the fourth category had 2.5 times the risk compared with those without detectable troponin I (P < 0.0001). These associations remained significant even for those individuals in whom levels of contemporary-sensitivity troponin I measures were not detectable. Addition of troponin I levels to clinical variables led to significant increases in risk prediction with significant improvement of the c-statistic (P < 0.0001) and net reclassification (P < 0.0001). A threshold of 4.7 pg/mL in women and 7.0 pg/mL in men is suggested to detect individuals at high risk for future cardiovascular events. Troponin I, measured with a high-sensitivity assay, is an independent predictor of cardiovascular events and might support selection of at risk individuals.
- 8 October 2013
- Published by Oxford University Press (OUP) in European Heart Journal
- Vol. 35 (5) , 271-281
Open AccessHigh population prevalence of cardiac troponin I measured by a high-sensitivity assay and cardiovascular risk estimation: the MORGAM Biomarker Project Scottish Cohort
Our aim was to test the prediction and clinical applicability of high-sensitivity assayed troponin I for incident cardiovascular events in a general middle-aged European population. High-sensitivity assayed troponin I was measured in the Scottish Heart Health Extended Cohort (n = 15 340) with 2171 cardiovascular events (including acute coronary heart disease and probable ischaemic strokes), 714 coronary deaths (25% of all deaths), 1980 myocardial infarctions, and 797 strokes of all kinds during an average of 20 years follow-up. Detection rate above the limit of detection (LoD) was 74.8% in the overall population and 82.6% in men and 67.0% in women. Troponin I assayed by the high-sensitivity method was associated with future cardiovascular risk after full adjustment such as that individuals in the fourth category had 2.5 times the risk compared with those without detectable troponin I (P < 0.0001). These associations remained significant even for those individuals in whom levels of contemporary-sensitivity troponin I measures were not detectable. Addition of troponin I levels to clinical variables led to significant increases in risk prediction with significant improvement of the c-statistic (P < 0.0001) and net reclassification (P < 0.0001). A threshold of 4.7 pg/mL in women and 7.0 pg/mL in men is suggested to detect individuals at high risk for future cardiovascular events. Troponin I, measured with a high-sensitivity assay, is an independent predictor of cardiovascular events and might support selection of at risk individuals.
- Open Access
- 10 December 2010
- Published by Oxford University Press (OUP) in International Journal of Epidemiology
- Vol. 40 (1) , 147-149
Commentary: descriptions and definitions of myocardial infarction--personal reminiscences and a challenge.
- 10 December 2010
- Published by Oxford University Press (OUP) in International Journal of Epidemiology
- Vol. 40 (1) , 147-149
Open AccessCommentary: descriptions and definitions of myocardial infarction--personal reminiscences and a challenge.
- Open Access
- 19 July 2006
- Published by Oxford University Press (OUP) in International Journal of Epidemiology
- Vol. 35 (4) , 1107
Preventing Chronic Diseases. A Vital Investment: WHO Global Report. Geneva: World Health Organization, 2005. pp 200. CHF 30.00. ISBN 92 4 1563001. Also published on http://www.who.int/chp/chronic_disease_report/en/
However much we may now think differently, until recently the standard method of representing those who suffer from myocardial infarction, hypertension, diabetes mellitus, cancer, or even simple obesity was through images of white middle-class Americans, or of others from the developed world. For decades this view prevented the generality of people in those countries from realizing that such diseases predominate among the socially deprived groups in their societies. Worldwide it gave rise to the myth that these were rich men's and rich countries' diseases, and in consequence not a subject that should concern politicians and health authorities in developing countries—or even the World Health Organization itself. At WHO Headquarters, under budgetary constraints, cardiovascular disease, cancer, and other non-communicable diseases were often given less emphasis than diseases that did not occur in or had largely disappeared from the developed world. Cardiovascular disease and cancer were voted down by the developing world, which regarded it as not their problem.
- 19 July 2006
- Published by Oxford University Press (OUP) in International Journal of Epidemiology
- Vol. 35 (4) , 1107
Open AccessPreventing Chronic Diseases. A Vital Investment: WHO Global Report. Geneva: World Health Organization, 2005. pp 200. CHF 30.00. ISBN 92 4 1563001. Also published on http://www.who.int/chp/chronic_disease_report/en/
However much we may now think differently, until recently the standard method of representing those who suffer from myocardial infarction, hypertension, diabetes mellitus, cancer, or even simple obesity was through images of white middle-class Americans, or of others from the developed world. For decades this view prevented the generality of people in those countries from realizing that such diseases predominate among the socially deprived groups in their societies. Worldwide it gave rise to the myth that these were rich men's and rich countries' diseases, and in consequence not a subject that should concern politicians and health authorities in developing countries—or even the World Health Organization itself. At WHO Headquarters, under budgetary constraints, cardiovascular disease, cancer, and other non-communicable diseases were often given less emphasis than diseases that did not occur in or had largely disappeared from the developed world. Cardiovascular disease and cancer were voted down by the developing world, which regarded it as not their problem.
Pattern of declining blood pressure across replicate population surveys of the WHO MONICA project, mid-1980s to mid-1990s, and the role of medication
Objective Declining mean systolic and diastolic blood pressures were observed in most populations of the World Health Organization MONICA (monitoring trends and determinants in cardiovascular disease) project from the mid-1980s to mid-1990s. We tested whether pooled results would show mean change associated with decline in high readings only, resulting from better antihypertensive medication, or with similar falls in low, middle, and high readings, implying other causes. Design Independent, random sample, cross sectional population surveys, each end of the MONICA decade. Setting 38 populations in 21 countries across four continents. Participants Design target in each survey of 200 participants in each 10 year age and sex group from age 35 to 64 Main outcome measures Changes in the population in mean systolic and diastolic blood pressure, and in low, middle, and high readings—the 20th, 50th, and 80th centiles—and the differences between these changes. Results Individual populations differed considerably, but pooling the 38 population results gave mean changes in systolic blood pressure of −2.2 mm Hg in men, −3.3 mm Hg in women, and in diastolic blood pressure of −1.4 mm Hg in men and −2.2 mm Hg in women (overall average −2.26 mm Hg, population median −1.55 mm Hg). Antihypertensive medication, associated with high readings, rose by 0.5% to 11.4%. However, average falls in low and middle blood pressure readings were so similar to those in high readings and in the mean that no effect from improving treatment of hypertension was detected. Results in contrasted subgroups were consistent. Conclusions Blood pressure fell across 38 MONICA populations at all levels of readings, with no differential fall in high readings attributable to better control of hypertension. Despite the importance of medication to individuals, in that decade other determinants of blood pressure lowering must have been more pervasive and powerful in whole populations.
Pattern of declining blood pressure across replicate population surveys of the WHO MONICA project, mid-1980s to mid-1990s, and the role of medication
Objective Declining mean systolic and diastolic blood pressures were observed in most populations of the World Health Organization MONICA (monitoring trends and determinants in cardiovascular disease) project from the mid-1980s to mid-1990s. We tested whether pooled results would show mean change associated with decline in high readings only, resulting from better antihypertensive medication, or with similar falls in low, middle, and high readings, implying other causes. Design Independent, random sample, cross sectional population surveys, each end of the MONICA decade. Setting 38 populations in 21 countries across four continents. Participants Design target in each survey of 200 participants in each 10 year age and sex group from age 35 to 64 Main outcome measures Changes in the population in mean systolic and diastolic blood pressure, and in low, middle, and high readings—the 20th, 50th, and 80th centiles—and the differences between these changes. Results Individual populations differed considerably, but pooling the 38 population results gave mean changes in systolic blood pressure of −2.2 mm Hg in men, −3.3 mm Hg in women, and in diastolic blood pressure of −1.4 mm Hg in men and −2.2 mm Hg in women (overall average −2.26 mm Hg, population median −1.55 mm Hg). Antihypertensive medication, associated with high readings, rose by 0.5% to 11.4%. However, average falls in low and middle blood pressure readings were so similar to those in high readings and in the mean that no effect from improving treatment of hypertension was detected. Results in contrasted subgroups were consistent. Conclusions Blood pressure fell across 38 MONICA populations at all levels of readings, with no differential fall in high readings attributable to better control of hypertension. Despite the importance of medication to individuals, in that decade other determinants of blood pressure lowering must have been more pervasive and powerful in whole populations.
By neglecting deprivation, cardiovascular risk scoring will exacerbate social gradients in disease: Table 1
Objective: To examine whether the efficiency and equity of cardiovascular risk scores that identify patients at high risk for preventive interventions are compromised by omitting social deprivation, which contributes to risk. Design: Cohort study. Setting: The SHHEC (Scottish heart health extended cohort) study of random sample risk factor surveys across 25 districts of Scotland in 1984–87 and North Glasgow in 1989, 1992, and 1995 Participants: 6419 men and 6618 women aged 30–74, free of cardiovascular disease at baseline, followed up with permission for mortality and morbidity to March 1997. Participants were allocated to population fifths of the Scottish index of multiple deprivation (SIMD) and their observed coronary risk was compared with that expected from the Framingham score for all coronary heart disease. Results: The Framingham score overestimated risk overall and in each SIMD fifth. It seriously underestimated the variation in risk with deprivation. The relative risk of observed 10 year coronary risk (sexes combined) analysed across population fifths had a steep gradient, from least to most deprived, of 1.00, 1.81, 1.98, 2.22, and 2.57. Expected risk, calculated from baseline risk factor values and the Framingham score, had one quarter of that gradient, with relative risks of 1.00, 1.17, 1.19, 1.28, and 1.36. Conclusion: Cardiovascular risk estimated by the Framingham and related scores is misleading in guiding treatment decisions among people at different levels of social deprivation. Such scores foster relative undertreatment of the socially deprived, exacerbating the social gradients in disease, which national policies seek to minimise. Debate and action are needed to correct this anomaly.
By neglecting deprivation, cardiovascular risk scoring will exacerbate social gradients in disease: Table 1
Objective: To examine whether the efficiency and equity of cardiovascular risk scores that identify patients at high risk for preventive interventions are compromised by omitting social deprivation, which contributes to risk. Design: Cohort study. Setting: The SHHEC (Scottish heart health extended cohort) study of random sample risk factor surveys across 25 districts of Scotland in 1984–87 and North Glasgow in 1989, 1992, and 1995 Participants: 6419 men and 6618 women aged 30–74, free of cardiovascular disease at baseline, followed up with permission for mortality and morbidity to March 1997. Participants were allocated to population fifths of the Scottish index of multiple deprivation (SIMD) and their observed coronary risk was compared with that expected from the Framingham score for all coronary heart disease. Results: The Framingham score overestimated risk overall and in each SIMD fifth. It seriously underestimated the variation in risk with deprivation. The relative risk of observed 10 year coronary risk (sexes combined) analysed across population fifths had a steep gradient, from least to most deprived, of 1.00, 1.81, 1.98, 2.22, and 2.57. Expected risk, calculated from baseline risk factor values and the Framingham score, had one quarter of that gradient, with relative risks of 1.00, 1.17, 1.19, 1.28, and 1.36. Conclusion: Cardiovascular risk estimated by the Framingham and related scores is misleading in guiding treatment decisions among people at different levels of social deprivation. Such scores foster relative undertreatment of the socially deprived, exacerbating the social gradients in disease, which national policies seek to minimise. Debate and action are needed to correct this anomaly.
- 27 October 2003
- Published by Springer Nature in Journal of Human Hypertension
- Vol. 17 (11) , 751-759
Trends and social factors in blood pressure control in Scottish MONICA surveys 1986–1995: the rule of halves revisited
Time trends and social factors in detection, treatment and control of hypertension in the community were examined in four independent Scottish MONICA cross-sectional surveys in 1986, 1989, 1992 and 1995. Residents aged 25–64 years were recruited randomly from general practice lists in north Glasgow, Scotland with stratification by sex and 10-year age groups. A total of 1262 participated in the first survey, 1397 in the second, 1516 in the third and 1836 in the fourth. Differences and trends in proportions of hypertension undetected, detected but untreated, treated but uncontrolled and controlled across the four surveys were tested by 2, and the associations of the poor control of hypertension with social factors were estimated by multivariate logistic regression model to derive odds ratios. Using the cut point of 160/95 mmHg, proportion of hypertension undetected across the four surveys was 56.3, 44.6, 32.0 and 38.2%, and of treated controlled hypertension was 15.2, 26.4, 32.0 and 32.8% (both trends P<0.001). Multivariate analysis showed that poor control of hypertension was not related to social deprivation, but significantly related to being male, young, of low body mass index and heavy alcohol drinking. Undetected hypertension was significantly related to full-time employment, and untreated hypertension to high social class and possibly education level. These findings suggest that in this part of Scotland the management of hypertension has improved, so the 'rule of halves' no longer applies. Control of blood pressure is not positively associated with social deprivation, but people at a high risk of poor control of hypertension should be targeted.
- 27 October 2003
- Published by Springer Nature in Journal of Human Hypertension
- Vol. 17 (11) , 751-759
Trends and social factors in blood pressure control in Scottish MONICA surveys 1986–1995: the rule of halves revisited
Time trends and social factors in detection, treatment and control of hypertension in the community were examined in four independent Scottish MONICA cross-sectional surveys in 1986, 1989, 1992 and 1995. Residents aged 25–64 years were recruited randomly from general practice lists in north Glasgow, Scotland with stratification by sex and 10-year age groups. A total of 1262 participated in the first survey, 1397 in the second, 1516 in the third and 1836 in the fourth. Differences and trends in proportions of hypertension undetected, detected but untreated, treated but uncontrolled and controlled across the four surveys were tested by 2, and the associations of the poor control of hypertension with social factors were estimated by multivariate logistic regression model to derive odds ratios. Using the cut point of 160/95 mmHg, proportion of hypertension undetected across the four surveys was 56.3, 44.6, 32.0 and 38.2%, and of treated controlled hypertension was 15.2, 26.4, 32.0 and 32.8% (both trends P<0.001). Multivariate analysis showed that poor control of hypertension was not related to social deprivation, but significantly related to being male, young, of low body mass index and heavy alcohol drinking. Undetected hypertension was significantly related to full-time employment, and untreated hypertension to high social class and possibly education level. These findings suggest that in this part of Scotland the management of hypertension has improved, so the 'rule of halves' no longer applies. Control of blood pressure is not positively associated with social deprivation, but people at a high risk of poor control of hypertension should be targeted.
Failing to bark and barking
Footnotes Competing interests HT-P was a project author and principal investigator in the WHO MONICA project. A longer version of this letter complete with references is available at bmj.com/cgi/eletters/325/7378/1490#30160
Failing to bark and barking
Footnotes Competing interests HT-P was a project author and principal investigator in the WHO MONICA project. A longer version of this letter complete with references is available at bmj.com/cgi/eletters/325/7378/1490#30160